Prescribed vitamin D and calcium preparations in patients treated with bone remodelling agents in primary care: a report of a pilot study

References

• National Institute for Clinical Excellence. Bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. January, 2005. (Available from www.nice.org.uk/pdf/TA087guidance.pdf [accessed 16 September 2005])
   Google Scholar
• Osteoporosis. Clinical guidelines for prevention and treatment. Update on pharmacological interventions and an algorithm for management. Royal College of Physicians and the Bone and Tooth Society of Great Britain, July, 2000. (Available from www.rcplondon.ac.uk/pubs/wp_osteo_update.htm [accessed 16 September 2005])
   Google Scholar
• Glucocorticoid-induced osteoporosis. Royal College of Physicians (London), the Bone and Tooth Society of Great Britain, and the National Osteoporosis Society, 2003. (Available from www. rcplondon.ac.uk/pubs/books/glucocorticoid/Glucocorticoid.pdf [accessed 16 September 2005])
   Google Scholar
• National Institute for Clinical Excellence Falls: the assessment and prevention of falls in older people. November, 2004. (Available from www.nice.org.uk/pdf/CG021fullguideline.pdf [accessed 16 September 2005])
   Google Scholar
• Scottish Intercollegiate Guidelines Network. Management of osteoporosis: A national clinical guideline, 71. June, 2003. (Available from www.sign.ac.uk/pdf/sign71.pdf [accessed 16 September 2005])
   Google Scholar
• Clinical Resource Efficiency Support Team. Guidance on the prevention and treatment of osteoporosis. March, 2001. (Available from www.crestni.org.uk/publications/osteo.pdf [accessed 16 September 2005])
   Google Scholar
• Department of Health. National Service Framework for Older People. March, 2001. (Available from www.dh.gov.uk/ assetRoot/04/07/12/83/04071283.pdf [accessed 16 September 2005])
   Google Scholar
• Department of Health. Nutrition and bone health: with particular reference to calcium and vitamin D. Report on Health and Social Subjects, 49. London, Department of Health, 1998
   Google Scholar
• Finch S, Doyle W, Lowe C et al. National diet and nutrition survey: people aged 65 years and over. London, HMSO, 1998
   Google Scholar
• Wharton B, Bishop N. Rickets. Lancet 2003;362:1389–1400
   PubMed Web of Science ®Google Scholar
• Dawson Hughes B, Heaney RP, Holick HF et al. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713–6
   PubMed Web of Science ®Google Scholar
• Heaney RP. Vitamin D: How much do we need, and how much is too much? Osteopor Int 2000;11:553–5
   PubMed Web of Science ®Google Scholar
• Hirani V, Primatesta P. Vitamin D concentrations among people aged 65 years and over living in private households and institutions in England: population survey. Age Ageing 2005;34:485–91
   PubMed Web of Science ®Google Scholar
• Gallacher SJ, McQuillian C, Harkness M et al. Prevalence of vitamin D inadequacy in Scottish adults with non-vertebral fragility fractures. Curr Med Res Opin 2005;21:1355–61
   PubMed Web of Science ®Google Scholar
• Moniz C, Dew T, Dixon T. Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London. Curr Med Res Opin 2005;21:1891–4
   Google Scholar
• Anderson F. Vitamin D for older people: how much, for whom and above all why? Age Ageing 2005;34:425–6
   PubMed Web of Science ®Google Scholar
• Grant AM, Avenell A, Campbell MK et al. RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005; 365:1621–8
   Google Scholar
• Porthouse J, Cockayne S, King C et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005; 330:1003–9
   PubMed Web of Science ®Google Scholar
• Anderson FH, Smith HE, Raphael HM et al. Effect of annual intramuscular vitamin D supplementation on fracture risk in 9440 community living older people: the Wessex Fracture Prevention Trial [abstract]. J Bone Miner Res 2004;19\(Suppl 1): Abstract No. 1220
   Google Scholar
• McCloskey E, Selby P, Davies M et al. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study. J Bone Miner Res 2004;19:728–36
   PubMed Web of Science ®Google Scholar
• Black DM, Cummings SR, Karpf DB et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996;348:1535–41
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC et al. Effect of vitamin D on falls: A meta-analysis. JAMA 2004;291:1999–2006
   PubMed Web of Science ®Google Scholar
• Cauley JA, Robbins J, Chen Z et al (2003). The effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. JAMA 2003;290:1729–38
   Google Scholar
• Data on file, Merck Sharp & Dohme Limited
   Google Scholar
• Kirthisingha VA, Beresford P, Bell N et al. Vitamin D status in patients taking bisphosphonate drugs. Osteoporos Int 2005;15 (Suppl 2):S29
   Google Scholar
• de Lusignan S, Valentin T, Chan T et al. Problems with primary care data quality: osteoporosis as an exemplar. Inform Primary Care 2004;12:147–156
   PubMedGoogle Scholar
• Bayly JR, Carter GM. A primary care programme to reduce the incidence of osteoporotic fracture. Osteoporos Int 2003;14 (Suppl 4):S2
   Google Scholar
• Brankin E, Mitchell C, Munro R on behalf of Lanarkshire Osteoporosis Service. Closing the osteoporosis gap in primary care: a secondary prevention of fracture programme. Curr Med Res Opin 2005;21:475–82
   Google Scholar
• Pal B. Questionnaire survey of advice given to patients with fractures. BMJ 1999;318:500–01
   PubMed Web of Science ®Google Scholar
• Canagon S, St Clair M, Fraser K et al. Long term management of people with fragility fracture is inadequate: an audit from Mid Sussex, UK. Osteoporo Int 2000;11:S38
   Google Scholar
• Torgerson DJ, Dolan P. Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis 1998;57:378–9
   PubMed Web of Science ®Google Scholar